Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China
· Delayed Price · Currency is CNY 30.41
+0.55 (1.84%)
Mar 10, 2026, 3:00 PM CST
Jiangsu Jibeier Pharmaceutical Company Description
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China.
The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases.
In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.
Jiangsu Jibeier Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,326 |
| CEO | Zhongyi Geng |
Contact Details
Address: Zhenjiang High-tech Industrial Development Park Zhenjiang China | |
| Phone | 86 51 1888 98101 |
| Website | jbepharm.com |
Stock Details
| Ticker Symbol | 688566 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004041 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhongyi Geng | GM and Chairman of the Board |
| Xinjun Yu | Vice Chairman of the Board and Deputy GM |
| Suofu Zhao | Financial Director |
| Jianzhong Zhai | Board Secretary |
| Haidao Li | Deputy Director of the Research Institute |
| Xufeng Qin | Deputy Director of the Research Institute |
| Zhaoguang Li | Director of the Synthesis Office of the Research Institute |
| Ying Wu | Deputy General Manager |
| Xiugen Wu | Institute Director |
| Zhi Lei Zhu | Accounting Supervisor |